Alpha Cognition Secures U.S. Patent for Alzheimer’s Drug

Alpha Cognition Inc (TSE:ACOG) has released an update.

Alpha Cognition Inc. has received a Notice of Allowance from the USPTO for its patented Alzheimer’s drug, ZUNVEYL, which strengthens its intellectual property protection in the U.S. until 2044. This milestone supports the company’s mission to develop innovative therapies for neurodegenerative diseases.

For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.